Britannia Life Sciences Inc.
BLAB
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.23% | 1,772.94% | -86.25% | -17.59% | 693.35% |
| Total Receivables | 103.29% | 88.48% | 45.06% | -6.87% | -79.96% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -31.03% | 435.87% | -2.13% | -44.71% | 27.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -1.52% | -74.91% | 0.97% | 4.17% | -- |
| Total Current Assets | 9.04% | 468.41% | -63.59% | -13.41% | 323.98% |
|
|
|||||
| Total Current Assets | 9.04% | 468.41% | -63.59% | -13.41% | 323.98% |
| Net Property, Plant & Equipment | -17.75% | -14.02% | -14.16% | -5.63% | -76.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.53% | 117.29% | 2.96% | -10.96% | -47.57% |
|
|
|||||
| Total Accounts Payable | -60.84% | 148.60% | -5.36% | -32.51% | 2.23% |
| Total Accrued Expenses | -16.23% | -13.79% | 38.83% | -12.94% | -15.67% |
| Short-term Debt | -1.42% | 0.00% | -2.30% | 6.37% | 3.03% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -4.21% | 2.06% | -3.27% | 4.68% | -92.92% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -41.08% | 60.83% | 11.95% | -23.80% | -68.62% |
|
|
|||||
| Total Current Liabilities | -41.08% | 60.83% | 11.95% | -23.80% | -68.62% |
| Long-Term Debt | -- | -- | 39.14% | 4.35% | -65.00% |
| Short-term Debt | -1.42% | 0.00% | -2.30% | 6.37% | 3.03% |
| Capital Leases | -30.77% | -30.80% | -24.32% | -12.69% | -51.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -36.44% | -6.75% | 20.88% | -15.39% | -67.45% |
|
|
|||||
| Common Stock & APIC | -1.53% | 1.59% | -2.08% | 5.39% | 0.10% |
| Retained Earnings | 158.18% | 84.02% | -0.80% | -10.87% | 31.55% |
| Treasury Stock & Other | -6.38% | 3.26% | -6.23% | -12.58% | -1,041.31% |
| Total Common Equity | 18.58% | 246.52% | -10.83% | -7.22% | 433.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.58% | 246.52% | -10.83% | -7.22% | 433.67% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.58% | 246.52% | -10.83% | -7.22% | 8.09% |
|
|
|||||